This study shows that lower levels of blood glucose and insulin were observed in the HFD-fed group with TFP treatment than those detected in HFD-fed animals receiving Vehicle, suggesting that TFP and TFP-like agents may hold potential for the treatment of obesity-associated hyperglycemia. This evidence concerns the gene INS and obesity disorder.